Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the spread of pancreatic cancer and increase survival in animal models.
In a study published in the March 5, 2021 online edition of Cerebral Cortex, researchers at University of California San Diego School of Medicine found that specific regions of the brain respond to emotional stimuli related to loneliness and wisdom in opposing ways.
Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health.
A study by researchers from the Salk Institute and UC San Diego opens a potential new avenue for clinical intervention in a psychiatric disease.
Seeking healthy lifestyle changes, Colin Jackson started running in 2014. He ran his first-ever mile in 28:47. He finished last in his first marathon. His pace, though, was irrelevant. The drive needed to complete 26.2 miles hooked him.
The Halıcıoğlu Data Science Institute (HDSI) is pleased to welcome Dexcom to our robust Industry Partnership Alliance Program.
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical diagnostic reports.
Tissues which consist largely of collagen were the focus of a recent collaborative study by a team from Stanford University and Purdue University. To accomplish their work, they used the Comet supercomputer at the San Diego Supercomputer Center at UC San Diego.
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.